Myelodysplastic syndromes (MDS), also known as myelodysplastic neoplasms, are conditions that can occur when the blood-forming cells in the bone marrow become abnormal, resulting in the marrow …

Oct 25, 2024 · Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly formed or don't work properly. Myelodysplastic syndromes result from something amiss in the …

Jul 10, 2023 · If you have myelodysplastic syndrome (MDS), you have a form of cancer that’s a chronic illness. No illness is easy, but having a chronic illness means also managing the emotional impact of …

Nov 21, 2024 · Myelodysplastic syndromes (MDS) are a rare group of disorders in which your body no longer makes enough healthy blood cells. With MDS, your bone marrow cells become abnormal and …

Myelodysplastic Syndrome (MDS) refers to a group of disorders in which the bone marrow produces too few mature and/or functioning red blood cells, white blood cells or platelets. It begins with a change …

Myelodysplastic syndrome (MDS) is a rare disease of the blood, only occurring in four out of every 1 million children. While it develops in older patients (greater than 60 years old) most of the time, it can …

Myelodysplastic syndromes, also called MDS or myelodysplasia, occur when the bone marrow fails to make enough healthy blood cells. Learn more about MDS.

Myelodysplastic syndromes (MDS) are a group of cancers that affect blood and bone marrow, with varying degrees of severity, treatments, and life expectancy.

Dec 5, 2025 · Low- and intermediate-risk myelodysplastic syndromes (LR-MDS and Int-MDS, respectively) are characterized by ineffective hematopoiesis, along with the presence of at least 10% …

Dec 6, 2025 · Based on that rationale, Garcia led a phase 1b trial investigating treatment of newly diagnosed patients with high-risk MDS with venetoclax plus azacitidine. That trial showed promising …